The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

被引:202
|
作者
Cheng, KY
Lowe, ED
Sinclair, J
Nigg, EA
Johnson, LN
机构
[1] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England
[2] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany
来源
EMBO JOURNAL | 2003年 / 22卷 / 21期
关键词
cell cycle control; Plk1; polo box domain; phospho-peptide recognition; protein structure;
D O I
10.1093/emboj/cdg558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human polo-like kinase Plk1 localizes to the centrosomes, kinetochores and central spindle structures during mitosis. It plays an essential role in promoting mitosis and cytokinesis through phosphorylation of a number of different substrates. Kinase activity is regulated by a conserved C-terminal domain, termed the polo box domain (PBD), which acts both as an autoinhibitory domain and as a subcellular localization domain. We have determined the crystal structure of Plk1 PBD (residues 367-603) to 2.2 Angstrom resolution and the structure of a phospho-peptide-PBD (residues 345-603) complex to 2.3 Angstrom resolution. The two polo boxes of the PBD exhibit identical folds based on a six-stranded beta-sheet and an alpha-helix, despite only 12% sequence identity. The phospho-peptide binds at a site between the two polo boxes. It makes a short antiparallel beta-sheet connection and critical contacts to residues Trp414, Leu490, His538 and Lys540. Most of these residues had been shown to be important for biological activity through mutational studies. The results provide an explanation for phospho-peptide recognition and create the basis for new functional studies.
引用
收藏
页码:5757 / 5768
页数:12
相关论文
共 50 条
  • [41] Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds
    Abdelfatah, Sara
    Fleischer, Edmond
    Klinger, Anette
    Wong, Vincent Kam Wai
    Efferth, Thomas
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 1 - 9
  • [42] Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1
    Sung Min Kim
    Min Kyung Chae
    Chulhyun Lee
    Min Su Yim
    Jeong Kyu Bang
    Eun Kyoung Ryu
    Amino Acids, 2014, 46 : 2595 - 2603
  • [43] Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1
    Kim, Sung Min
    Chae, Min Kyung
    Lee, Chulhyun
    Yim, Min Su
    Bang, Jeong Kyu
    Ryu, Eun Kyoung
    AMINO ACIDS, 2014, 46 (11) : 2595 - 2603
  • [44] Vitamin E-Conjugated Phosphopeptide Inhibitor of the Polo-Box Domain of Polo-Like Kinase 1
    Yim, Min Su
    Soung, Nak Kyun
    Han, Eun Hee
    Min, Jin-Young
    Han, Hojin
    Son, Eun-Ju
    Kim, Hak Nam
    Kim, BoYeon
    Bang, Jeong Kyu
    Ryu, Eun Kyoung
    MOLECULAR PHARMACEUTICS, 2019, 16 (12) : 4867 - 4877
  • [45] Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
    Sang-Moon Yun
    Tinoush Moulaei
    Dan Lim
    Jeong K Bang
    Jung-Eun Park
    Shilpa R Shenoy
    Fa Liu
    Young H Kang
    Chenzhong Liao
    Nak-Kyun Soung
    Sunhee Lee
    Do-Young Yoon
    Yoongho Lim
    Dong-Hee Lee
    Akira Otaka
    Ettore Appella
    James B McMahon
    Marc C Nicklaus
    Terrence R Burke Jr
    Michael B Yaffe
    Alexander Wlodawer
    Kyung S Lee
    Nature Structural & Molecular Biology, 2009, 16 : 876 - 882
  • [46] Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1
    Sun, Juan
    Liu, Han-Yu
    Xu, Ruo-Fei
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (24) : 6581 - 6588
  • [47] Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1
    Richter, Susan
    Neundorf, Ines
    Loebner, Kristin
    Graeber, Martin
    Berg, Thorsten
    Bergmann, Ralf
    Steinbach, Joerg
    Pietzsch, Jens
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) : 4686 - 4689
  • [48] A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
    Gatz, Susanne A.
    Aladowicz, Ewa
    Casanova, Michela
    Chisholm, Julia C.
    Kearns, Pamela R.
    Fulda, Simone
    Geoerger, Birgit
    Schaefer, Beat W.
    Shipley, Janet M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors
    Lin, Tong-yuan
    Min, Hong-ping
    Jiang, Cheng
    Niu, Miao-miao
    Yan, Fang
    Xu, Li-li
    Di, Bin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3429 - 3437
  • [50] Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds
    Sara Abdelfatah
    Edmond Fleischer
    Anette Klinger
    Vincent Kam Wai Wong
    Thomas Efferth
    Investigational New Drugs, 2020, 38 : 1 - 9